Antiproliferative activity and apoptosis inducing effects of nitric oxide donating derivatives of evodiamine

Bioorg Med Chem. 2016 Jul 1;24(13):2971-2978. doi: 10.1016/j.bmc.2016.05.001. Epub 2016 May 3.

Abstract

The first series of nitric oxide donating derivatives of evodiamine were designed and prepared. NO releasing ability of all target derivatives was evaluated in BGC-823, Bel-7402 and L-02 cells. The cytotoxicity was evaluated against three human tumor cell lines (Bel-7402, A549 and BGC-823) and normal human liver cells L-02. The nitrate derivatives 11a and 11b only exhibited moderate activity and furoxan-based derivatives 13a-c, 14a and 14b showed promising activity. 13c showed good cytotoxic selectivity between tumor and normal liver cells and was further investigated for its apoptotic properties on human hepatocarcinoma Bel-7402 cells. The molecular mode of action revealed that 13c caused cell-cycle arrest at S phase and induced apoptosis in Bel-7402 cells through mitochondria-related caspase-dependent pathways.

Keywords: Antiproliferative activity; Apoptosis; Evodiamine; Nitric oxide.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Agents / toxicity
  • Apoptosis / drug effects*
  • Blotting, Western
  • Cell Cycle
  • Cell Line
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Cell Survival / drug effects
  • Humans
  • Inhibitory Concentration 50
  • Molecular Structure
  • Nitric Oxide / chemistry*
  • Quinazolines / chemistry*
  • Quinazolines / pharmacology*
  • Quinazolines / toxicity

Substances

  • Antineoplastic Agents
  • Quinazolines
  • Nitric Oxide
  • evodiamine